COMP <GO>
TECH vs UNH // REVENUE GROWTH (YOY)
Bio-Techne Corp (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TECH 7
— UNH 7
▲ REVENUE GROWTH (YOY) LEADER: TECH
LAST: $72.67 (+0.01%) • MKT CAP: $11.40B
revenue-growth
5.20%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TECH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.80% | 88.31% | -23.51 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | 12.38% | -8.98 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 91.3x | 15.3x | +76.03 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 2.25% | 6.25% | -4.00 | UNH | /fcf-yield <GO> |
| Operating Margin | 8.40% | 5.32% | +3.08 | TECH | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 3.53% | +2.47 | TECH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 5.20% | 3.33% | +1.87 | TECH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.44% | 2.29% | -1.85 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.12 | 3.09 | +4.03 | TECH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TECH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 55.1 | +1.50 | TECH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.33 | +0.55 | TECH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 17.7x | +122.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.40B | $359.43B | -$348.04B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TECH REV | UNH REV | TECH GROSS % | UNH GROSS % | TECH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.22B | $447.57B | 64.8% | 88.7% | $256.6M | $16.07B |
| FY 2024 | $1.16B | $400.28B | 66.4% | 88.3% | $236.1M | $20.70B |
| FY 2023 | $1.14B | $371.62B | — | 89.6% | $203.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECH // BETA 0.88
UNH // BETA 0.33